💊 Jublia Generics: Which Product Should You Choose?

Hello, this is Yonsei Bomvit Dermatology, a dermatology clinic in Guro Digital Complex.

After the patent for Jublia, a nail fungus treatment containing efinaconazole, expired, various pharmaceutical companies released generic products, greatly expanding treatment options.

However, as the number of products has grown, many people are wondering what criteria they should use when choosing one.

Today, we will introduce the major generic products that have been approved by the Ministry of Food and Drug Safety so far,

and explain a few features to consider when choosing a product from the perspective of a dermatologist.

Jublia generics: Which product should you choose?

✅ Jublia generics: Which companies have released them?

The Jublia generic products that have been released in Korea so far, or are being prepared for release, are as follows.

(This list is based on Ministry of Food and Drug Safety product approval, and the launch timing may vary depending on distribution conditions.)

• Epizol (Medica Korea)

• Efinazole Topical Solution (Dongkoo Bio & Pharma)

• Juplye (Daewoong Pharmaceutical)

• Epinia (OS Korea Pharmaceutical)

• Kayzol (Genewon Science)

• Epinail (JW Pharmaceutical)

• Bartoben (Genupharm)

• Nubla (Korea Union Pharmaceutical)

• Epinabel (Chong Kun Dang)

• Onicure (Farmgenscience)

• Neblia (Vivozon Pharmaceutical)

• Jubliem (Mothers Pharmaceutical)

• Pharma Efinaconazole (Korea Pharma)

All of these products are based on the same active ingredient (10% efinaconazole), and they are medicines whose quality and safety have been verified according to Ministry of Food and Drug Safety approval standards.

💡 What criteria should you use when choosing?

There is no difference in efficacy between Jublia generic products.

However, from the patient's perspective, the following criteria can be considered:

• Pharmaceutical company distribution stability → whether the product is easy to obtain at pharmacies

• Container convenience and differences in formulation → ease of use in actual application, such as the feel of use and the size of the area to be applied

• Price → since this is a non-covered medication, prices may vary by pharmacy. Consultation with the pharmacy is needed

• Brand recognition → some patients may feel more psychologically confident about products from large pharmaceutical companies

The emphasis differs depending on each company's marketing materials, and prices and distribution methods vary by pharmacy.

💬 Frequently asked questions in dermatology consultations

• “Will the effect be the same if I use a generic?” → Yes. The active ingredient, 10% efinaconazole, is the same, and these are medicines approved by the Ministry of Food and Drug Safety.

• “Prices vary so much, which one is better?” → It depends on the supply price and distribution channel of each pharmacy, so rather than treatment effect, choose based on convenience of use and accessibility.

• “Is there any difference from the original Jublia?” → The efficacy is the same, but there may be differences in container design, pharmacy price, and brand recognition.

In closing

The release of Jublia generics gives patients more options and is a positive change that can reduce the burden of treatment costs.

At Yonsei Bomvit Dermatology, we carefully guide each patient on the appropriate medication choice, treatment method, and treatment duration, taking their individual condition and circumstances into account.

Do not leave nail fungus untreated for too long.

Even a brief consultation can change the direction of treatment.

📍 Yonsei Bomvit Dermatology

📞 02-837-8275

#YonseiBomvitDermatology #GuroDigitalComplexDermatology #DermatologySpecialist #NailFungus #Athlete'sFootTreatment #JubliaGeneric #Efinaconazole #TopicalFungusMedicine #Juplye #Epinail #Epinabel #Kayzol #Epinia #NailFungusTreatment #FungusDermatology #FungusMedicineRecommendation #SkinConditionConsultation #NailCare #DermatologyConsultation #SkinMedicineInfo